Cancer Prevention Pharmaceuticals Starts Phase III Clinical Trial

Tucson-based Cancer Prevention Pharmaceuticals Inc. announced the launch of a three-year, Phase III colon-cancer-prevention trial in collaboration with the National Cancer Institute and SWOG (formerly the Southwest Oncology Group), an NCI-supported clinical-trials group.

Read more: Tucson company launching late-stage clinical trial for its cancer-prevention drug